Is Adderall XR (mixed amphetamine salts) an immediate-release or extended-release formulation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adderall XR is Extended-Release

Adderall XR is an extended-release formulation, not immediate-release. 1

Formulation Details

The "XR" in Adderall XR stands for "extended-release." This is a once-daily formulation that uses a unique dual-bead delivery system 1:

  • Two types of drug-containing beads designed to give a double-pulsed delivery of amphetamines
  • First pulse: Immediate-release beads release approximately 50% of the dose upon ingestion
  • Second pulse: Delayed-release beads release the remaining 50% approximately 4 hours later

Pharmacokinetic Profile

The extended-release nature is evident in its pharmacokinetics 1:

  • Time to peak concentration (Tmax): Approximately 7 hours for Adderall XR
  • Comparison: This is about 4 hours longer than immediate-release Adderall (Tmax ~3 hours)
  • Duration of action: Provides 12 hours of symptom coverage 2
  • Onset: Rapid onset within 1.5 hours despite being extended-release 2

Clinical Equivalence

A single 20 mg dose of Adderall XR provides comparable plasma concentrations to immediate-release Adderall 10 mg given twice daily (at 8 AM and 12 noon), spaced 4 hours apart 1. This makes it suitable for once-daily morning dosing, eliminating the need for midday doses at school or work.

Distinction from Immediate-Release

Regular Adderall (without the XR designation) is the immediate-release formulation. The extended-release technology in Adderall XR was specifically developed to prolong amphetamine release compared to conventional immediate-release tablets 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.